发明名称 |
USE OF CYSTEINE-RICH WHEY DERIVED PROTEIN IN PATIENTS RECEIVING CHEMOTHERAPY OR RADIOTHERAPY TO IMPROVE PATIENT SURVIVAL |
摘要 |
<p>A cysteine-rich undenatured whey-derived protein formulation did not interfere with the tumor-cytotoxic effects of chemotherapy and radiation therapy and did not have a negative effect on the clinical outcome, that is, negatively affect survival and increase mortality. Indeed, use of a high-cysteine undenatured whey derived protein in the treatment of cancer patients resulted in an increase in patient survival.</p> |
申请公布号 |
WO2010028503(A1) |
申请公布日期 |
2010.03.18 |
申请号 |
WO2009CA01277 |
申请日期 |
2009.09.11 |
申请人 |
2458781 CANADA INC.;DROGE, DR. WULF;BOUNOUS, DR. GUSTAVO;MONSON, JOHN H. |
发明人 |
DROGE, DR. WULF;BOUNOUS, DR. GUSTAVO;MONSON, JOHN H. |
分类号 |
A61K35/20;A61K38/17;A61P35/00;A61P39/06 |
主分类号 |
A61K35/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|